pharma packaging

With this acquisition Nemera establishes an operational footprint in Brazil and expands its product and services offering to better serve the pharmaceutical industry in Latin America.

Extensive machinery investments made as company experiences significant growth period due to COVID-19 related demand for specialized packaging.

Auburn, AL, April 28, 2021 – Aptar CSP Technologies, a leader in material science and active packaging solutions (part of AptarGroup, Inc.), announced its Activ-Film™ technology protects two new at-home COVID-19 tests that recently received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA).

The tests were developed by a leading manufacturer of diagnostic healthcare solutions and offer prescription and OTC (Over the Counter) COVID-19 at-home testing options without the need to visit a doctor’s office

• New AmSky™ blister system, the latest in Amcor’s recent innovation breakthroughs, has the potential to transform the sustainability of healthcare packaging
• Innovation eliminates PVC from blister packaging – enabling Amcor healthcare customers to improve the recyclability of their packaging
• Innovation will deliver the first child-resistant and senior-friendly (CRSF) recyclable solution for the most in-demand pharmaceutical packaging typ

Building on its recent track record of breakthrough innovations to deliver recyclable packaging, Amcor is today announcing c

Certification affirms the company’s quality management systems meets ISO requirements

Auburn, AL, April 20, 2021 – Aptar CSP Technologies, a leader in material science and active packaging solutions (part of AptarGroup, Inc.), earned the International Organization for Standardization ISO 13485:2016 certification for both its U.S. and France-based plants. These internationally recognized standards set the requirements for a quality management system specific to the medical device industry.

Diabetes patients depending on lifelong insulin treatment have to administer the vital medication to themselves using insulin pumps, syringes or pens. Ypsomed offers UnoPen™, a disposable pen with variable dose setting, for this and other multidose therapies. Schreiner MediPharm has developed an NFC-Label for this injection aid that serves as a communication interface between the injector and the SmartPilot™—an electronic pen add-on. The resulting smart device interactively supports patients in using the pen and helps them adhere to their therapy plans.